ArticleBlood advances2021

First-in-human phase 1 trial of induced regulatory T cells for graft-versus-host disease prophylaxis in HLA-matched siblings.

Margaret L MacMillan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.